- Study at Deakin
- Campus life
- Industry and community
- About Deakin
A Mellick (G)
3 x 1 hour lectures per week, and as online exercises, case studies, debates and discussions
Online teaching methods require internet access. Please refer to the most current computer specifications.
This unit describes how therapeutic targets are identified and how new therapies are developed for human use. It will provide an overview of the major therapeutic classes, including synthetic compounds, natural products, vaccines, nutriceuticals and other biological agents, and covers the therapeutic development pipeline, encompassing target identification and validation, therapeutic discovery and development, pre-clinical trials and toxicity testing.
Mid-semester test (45 minutes) 20%, written report (1200 words) 25%, case study (1200 words) 25%, examination (2 hours) 30%
Rang HP. 2006. Drug Discovery and Development: Technology in Transition. 1st Ed. Churchill Livingstone, Edinburgh, UK
Unit Fee Information
|Student Contribution Rate*||Student Contribution Rate**||Fee rate - Domestic Students||Fee rate - International students|
* Rate for all CSP students, except for those who commenced Education and Nursing units pre 2010
** Rate for CSP students who commenced Education and Nursing units pre 2010
Please note: Unit fees listed do not apply to Deakin Prime students.